Life sciences

Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
→
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference
→
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
→
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
→
Video: Early Cancer Detection With Delfi
→
Video: Reengineering Drug Discovery With Recursion
→
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna
→
Announcing the Digital Health Founder’s Fellowship
→
Our Investment In Qualio: A New Breed of Quality Management System for Life Sciences
→
Life Science Is Being Transformed by Vertical SaaS
→

The 5 Ps of Therapeutics Investing at Menlo
→


We Are Hiring a Principal with Therapeutics Expertise: Building a Biotech Franchise at Menlo
→

Pliant and the 5 Ps of Therapeutics Investing at Menlo
→

Investing in H1: SaaS Healthcare Analytics
→

Bringing Transparency to Healthcare Transactions: Menlo Ventures Invests in Rivet
→

Investing in Benchling: Software Accelerating Life Science Innovation
→

Menlo Ventures’ Greg Yap Selected for Aspen Institute’s Health Innovators Fellowship
→

Menlo Announces New $450 Million Fund to Invest in Iconic Entrepreneurs
→
